Home Digestive Disorders IBD: Crohn’s Disease What’s Health Canada Saying about Biosimilars?

IBD: Crohn's Disease

What’s Health Canada Saying about Biosimilars?

A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!

This video was made possible by an unrestricted educational grant by Pfizer Canada. 

What’s Health Canada Saying about Biosimilars?

[embed]https://www.youtube.com/watch?v=1OeDtXWn3_8[/embed]
A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!
Close

Where are you experiencing discomfort?

Click on the buttons on the body to the left or click from the list below where you are experiencing discomfort.